| Literature DB >> 32639332 |
Kazushi Fujimoto1, Tatsuo Nagata1, Itsuka Matsushita1, Kazuma Oku1, Mamika Imagawa1, Kazuki Kuniyoshi2, Takaaki Hayashi3, Kenichi Kimoto4, Masahito Ohji5, Shunji Kusaka2, Hiroyuki Kondo1.
Abstract
PURPOSE: To determine the characteristics of fundus autofluorescence (FAF) images and visual functions in eyes with Stickler syndrome using ultra-widefield FAF images.Entities:
Mesh:
Year: 2021 PMID: 32639332 PMCID: PMC7889284 DOI: 10.1097/IAE.0000000000002879
Source DB: PubMed Journal: Retina ISSN: 0275-004X Impact factor: 3.975
Fig. 1.Ultra-widefield FAF (UW-FAF) images and corresponding color fundus and fluorescein angiographic images in eyes with stickler syndrome. The images in the left column are from the left eye of a 13-year-old boy (patient 14), and the images in the right column are from the left eye of a 49-year-old man (patient 26). Top: FAF images representing predominantly hyperfluorescent AF pattern (left) and predominantly hypofluorescent AF pattern (right). Abnormal AF lesions are categorized into hyperfluorescent AF (white arrows) or hypofluorescent AF lesions (white arrowheads). Photocoagulation scars can be seen as hypofluorescent AF spots (back arrows) on the posterior margin of the stickler syndrome-associated AF lesion. Middle: Color fundus photographs showing varying degree of pigmentary changes along the retinal vessels, the so-called radial paravascular retinal degeneration. The changes correspond to the hyper- or hypofluorescent AF changes in the FAF images are shown by identical arrows or arrowheads. Bottom: Fluorescein angiographic images showing window defects corresponding to the hypofluorescent AF lesions in the FAF images shown by the arrowheads. Note that the abnormalities are not shown corresponding to hyperfluorescent AF lesions in the FAF images.
Summary of Fundus Autofluorescent Features and Visual Field Defects in Patients With Stickler Syndrome
| Patient No. | Family | Kinship | Sex | Age at Examination (yo) | R/L | Refraction (Diopters) | BCVA | Predominant FAF Status | Visual Field Defect at Maximum Level of Isopter: Associated Findings | Remarks | Patient No of Early Report (Reference) |
| 1 | 1 | Proband | F | 5 | R | −5 | 20/25 | None | None | Not listed | |
| L | −5 | 20/25 | None | None | |||||||
| 2 | 2 | Proband | F | 5 | R | −14.5 | 20/66 | None | NA | Not listed | |
| L | −13.0 | 20/40 | Hyperfluorescent | NA | |||||||
| 3 | 3 | Proband | M | 7 | R | −10 | 20/16 | None | NA | 22 (15) | |
| L | −13 | 20/33 | None | NA | |||||||
| 4 | 3 | Ant | F | 25 | R | −7.25 | 20/66 | Hypofluorescent | V4: O/O/O/U | R) Cat (27 yo), L) Cat (28 yo), FAF:B) Macular hyperfluorescent AF spot, B) circumferential hypoflurecent AF to the equator | 24 (15) |
| L | −14.5 | 20/28 | Hypofluorescent | V4: O | |||||||
| 5 | 3 | Mother | F | 29 | L | −15.87 | 20/25 | None | V4: Av | Cat (28 yo), FAF: Macular hyperfluorescent spot, FA: temporal avascular | 23 (15) |
| 6 | 4 | Proband | F | 9 | R | −12 | 20/66 | Hyperfluorescent | None | Not listed | |
| L | −12 | 20/40 | Hyperfluorescent | None | |||||||
| 7 | 5 | Proband | M | 10 | L | −6.75 | 20/25 | None | I4c: U | 23 (2) | |
| 8 | 6 | Proband | M | 10 | R | −14 | 20/33 | Hyperfluorescent | NA | 13 (15) | |
| L | −12.75 | 20/200 | Hyperfluorescent | NA | |||||||
| 9 | 7 | Proband | M | 10 | L | −14 | 20/22 | None | V4: Pc | Vit (9 yo) | 1 (15) |
| 10 | 7 | Mother | F | 35 | R | −4.5 | 20/20 | Hypofluorescent | V4: R/Pc | L) Vit (35 yo) | 2 (15) |
| L | −5.5 | 20/20 | Hypofluorescent | V4: O/Pc | |||||||
| 11 | 7 | Sister | F | 4 | R | −9 | 20/50 | Hyperfluorescent | NA | 3 (15) | |
| L | −9 | 20/20 | Hyperfluorescent | NA | |||||||
| 12 | 8 | Proband | F | 12 | R | −7.75 | 20/28 | Hypofluorescent | V4: R/O/O | 9 (15) | |
| L | −7.75 | 20/40 | Hyperfluorescent | V4: R/R | |||||||
| 13 | 8 | Mother | F | 35 | R | −6.25 | 20/20 | Hyperfluorescent | None | 11 (15) | |
| L | −3.75 | 20/40 | Hyperfluorescent | I4e: R | |||||||
| 14 | 9 | Proband | M | 13 | R | −5.25 | 20/20 | Hyperfluorescent | I4e: R/O | 27 (2) | |
| L | −4.75 | 20/16 | Hyperfluorescent | I4e: R/R | |||||||
| 15 | 10 | Proband | M | 14 | R | −7.5 | 20/20 | Hyperfluorescent | V4: U | L) Vit (10 yo) | 8 (15) |
| L | −6.25 | 20/16 | None | V4: Pc | |||||||
| 16 | 11 | Proband | M | 15 | R | −11 | 20/22 | Hyperfluorescent | None | 21 (15) | |
| L | −13.25 | 20/22 | Hyperfluorescent | V4: R | |||||||
| 17 | 12 | Proband | M | 15 | R | −8 | 20/16 | Hypofluorescent | V4: O/U | B) Cryo | 5 (15) |
| L | −7 | 20/22 | Hypofluorescent | V4: O/U | |||||||
| 18 | 13 | Proband | M | 17 | R | −14 | 20/33 | Hypofluorescent | NA | R) ENC/Vit/Cat (17 yo), L) ENC (14 yo) | 4 (15) |
| L | −10 | 20/16 | Hypofluorescent | NA | |||||||
| 19 | 14 | Proband | M | 18 | R | −3.5 | 20/66 | Hypofluorescent | V4: R/O | R) Vit (14 yo) | 6 (15) |
| L | −5.25 | 20/20 | Hypofluorescent | I4e: O | |||||||
| 20 | 15 | Proband | M | 27 | R | −8 | 20/16 | Hypofluorescent | V4: O | 12 (15) | |
| 21 | 16 | Proband | F | 30 | R | −9 | 20/22 | Hypofluorescent | V4: O/O/O/O/O/U | Not listed | |
| L | −10 | 20/20 | Hypofluorescent | V4: O/O/O/O/U/U | |||||||
| 22 | 17 | Proband | M | 36 | L | −18 | 20/16 | Hypofluorescent | V4: O | 6 (15) | |
| 23 | 18 | Proband | F | 37 | R | −11 | 20/133 | Hypofluorescent | NA | 19 (2) | |
| L | −12.25 | 20/40 | Hypofluorescent | NA | |||||||
| 24 | 19 | Proband | F | 39 | R | −14 | 20/66 | Hypofluorescent | V4: O/O/O/O/O/O/O | B) Cat (40 yo) | 15 (15) |
| L | −10 | 20/33 | Hypofluorescent | V4: O/O/O/O/O/O/O | |||||||
| 25 | 19 | Daughter | F | 13 | R | −8 | 20/66 | Hypofluorescent | V4: O/O/O/O/O/Pc | Not listed | |
| L | −12 | 20/20 | Hypofluorescent | V4: R/U | |||||||
| 26 | 20 | Father | M | 49 | L | −10.25 | 20/22 | Hypofluorescent | V4: Pc | 20 (15) |
Note that “V4: O/O/O/U” indicates four visual field defects found at an isopter level of V4 consisting of three hypofluorescent AF lesions (O) and one lesion due to undetermined cause (U).
Status before surgery.
Av, avascularization; B, both eyes; BCVA, best-corrected visual acuity; Cat, cataract surgery; Cryo, cryotherapy; ENC, encircling; NA, not analyzed; O, hypofluorescent; Pc, photocoagulation; R, hyperfluorescent; U, undetermined; Vit, vitrectomy, yo, year-old.
Fig. 2.Ultra-widefield FAF (UW-FAF) image and visual field defects detected by Goldmann perimetry of the right eye of a 39-year-old woman with stickler syndrome (patient 24). Left: UW-FAF image showing a predominantly hypofluorescent AF pattern. Right: Goldmann perimetry showing visual field defects that correspond to hypofluorescent AF lesions (numbers one through 6).
Fig. 3.Swept-source optical coherence tomographic (SS-OCT) and ultra-widefield FAF (UW-FAF) images showing changes in the left eye of an 18-year-old young man (patient 19). Top left: Fundus photograph nasal to the posterior pole showing mild pigmentary changes along with an upper nasal vessel. Top right: Part of UW-FAF image superimposed on the fundus photograph showing hypofluorescent AF. Bottom: B-scan SS-OCT image along the lesion of the hypofluorescent AF designated by the green vertical line of the fundus photograph. This photograph demonstrates the regional absence of the ellipsoid zone and the outer nuclear layer and a thinning of the inner retinal layers. The corresponding extent is shown by the lines between the arrows in the three images.